Cochlear's Outlook Moderates on U.S. Consumer Sentiment

Dow Jones

Jun 30

0013 GMT - Cochlear's earnings outlook continues to moderate due to the ongoing decline in U.S. consumer sentiment, according to a note from one of Macquarie's analysts. The analyst observes that sentiment has got even worse since the Australia-listed hearing-implant maker downgraded its FY 2026 guidance in April. They tell clients that consumer pressures remain centered on cost-of-living and inflation pressures, which erodes their confidence in implant demand. They reduce their FY 2026 underlying net profit forecast by about 3% to A$306 million, with similar cuts over the next two fiscal years. Macquarie keeps a neutral rating on the stock but raises its target price 3.5% to 119.00 Australian dollars on an updated weighted risk-free rate. Shares are down 0.9% at A$120.04. (stuart.condie@wsj.com)

(END) Dow Jones Newswires

June 29, 2026 20:13 ET (00:13 GMT)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/news/2647880955"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2647880955\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2647880955?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-30 08:13","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2647880955","market":"sg","top_or_hot":-1,"title":"Cochlear's Outlook Moderates on U.S. Consumer Sentiment","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     0013 GMT - Cochlear's earnings outlook continues to moderate due to the ongoing decline in U.S. consumer sentiment, according to a note from one of <a href=\"https://laohu8.com/S/MQG.AU\">Macquarie</a>'s analysts. The analyst observes that sentiment has got even worse since the Australia-listed hearing-implant maker downgraded its FY 2026 guidance in April. They tell clients that consumer pressures remain centered on cost-of-living and inflation pressures, which erodes their confidence in implant demand. They reduce their FY 2026 underlying net profit forecast by about 3% to A$306 million, with similar cuts over the next two fiscal years. Macquarie keeps a neutral rating on the stock but raises its target price 3.5% to 119.00 Australian dollars on an updated weighted risk-free rate. Shares are down 0.9% at A$120.04. (stuart.condie@wsj.com) \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  June 29, 2026 20:13 ET (00:13 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Cochlear's Outlook Moderates on U.S. Consumer Sentiment</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCochlear's Outlook Moderates on U.S. Consumer Sentiment\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2026-06-30 08:13</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     0013 GMT - Cochlear's earnings outlook continues to moderate due to the ongoing decline in U.S. consumer sentiment, according to a note from one of <a href=\"https://laohu8.com/S/MQG.AU\">Macquarie</a>'s analysts. The analyst observes that sentiment has got even worse since the Australia-listed hearing-implant maker downgraded its FY 2026 guidance in April. They tell clients that consumer pressures remain centered on cost-of-living and inflation pressures, which erodes their confidence in implant demand. They reduce their FY 2026 underlying net profit forecast by about 3% to A$306 million, with similar cuts over the next two fiscal years. Macquarie keeps a neutral rating on the stock but raises its target price 3.5% to 119.00 Australian dollars on an updated weighted risk-free rate. Shares are down 0.9% at A$120.04. (stuart.condie@wsj.com) \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  June 29, 2026 20:13 ET (00:13 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK7007","symbol_name":"医疗保健设备","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2647880955","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2647880955","pubTimestamp":1782778380,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"0013 GMT - Cochlear's earnings outlook continues to moderate due to the ongoing decline in U.S. consumer sentiment, according to a note from one of Macquarie's analysts. The analyst observes that sentiment has got even worse since the Australia-listed hearing-implant maker downgraded its FY 2026 guidance in April. They tell clients that consumer pressures remain centered on cost-of-living and inflation pressures, which erodes their confidence in implant demand. They reduce their FY 2026 underlying net profit forecast by about 3% to A$306 million, with similar cuts over the next two fiscal years. Macquarie keeps a neutral rating on the stock but raises its target price 3.5% to 119.00 Australian dollars on an updated weighted risk-free rate. Shares are down 0.9% at A$120.04.  Dow Jones NewswiresJune 29, 2026 20:13 ET Copyright  2026 Dow Jones & Company, Inc.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK7007":"医疗保健设备","COH.AU":"COCHLEAR LTD"},"translate_title":"科利耳对美国消费者信心的展望放缓","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"COH.AU":0.9},"content_text":"0013 GMT - Cochlear's earnings outlook continues to moderate due to the ongoing decline in U.S. consumer sentiment, according to a note from one of Macquarie's analysts. The analyst observes that sentiment has got even worse since the Australia-listed hearing-implant maker downgraded its FY 2026 guidance in April. They tell clients that consumer pressures remain centered on cost-of-living and inflation pressures, which erodes their confidence in implant demand. They reduce their FY 2026 underlying net profit forecast by about 3% to A$306 million, with similar cuts over the next two fiscal years. Macquarie keeps a neutral rating on the stock but raises its target price 3.5% to 119.00 Australian dollars on an updated weighted risk-free rate. Shares are down 0.9% at A$120.04. (stuart.condie@wsj.com) \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 29, 2026 20:13 ET (00:13 GMT)\n\n\n  Copyright (c) 2026 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":true,"need_login_tip":false,"code":"91000000","status":"200"}}}